Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,628
archived clinical trials in
Schizophrenia

A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site 018
1776
mi
from 98109
Little Rock, AR
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site 018
1776
mi
from 98109
Little Rock, AR
Click here to add this to my saved trials
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site 012
976
mi
from 98109
Cerritos, CA
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site 012
976
mi
from 98109
Cerritos, CA
Click here to add this to my saved trials
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site 010
991
mi
from 98109
Costa Mesa, CA
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site 010
991
mi
from 98109
Costa Mesa, CA
Click here to add this to my saved trials
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site 026
964
mi
from 98109
Culver City, CA
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site 026
964
mi
from 98109
Culver City, CA
Click here to add this to my saved trials
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site 004
981
mi
from 98109
Long Beach, CA
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site 004
981
mi
from 98109
Long Beach, CA
Click here to add this to my saved trials
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site
1031
mi
from 98109
Oceanside, CA
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site
1031
mi
from 98109
Oceanside, CA
Click here to add this to my saved trials
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site 42
973
mi
from 98109
Paramount, CA
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site 42
973
mi
from 98109
Paramount, CA
Click here to add this to my saved trials
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site 007
1060
mi
from 98109
San Diego, CA
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site 007
1060
mi
from 98109
San Diego, CA
Click here to add this to my saved trials
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site 008
2322
mi
from 98109
Washington,
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site 008
2322
mi
from 98109
Washington,
Click here to add this to my saved trials
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site 15
2512
mi
from 98109
Leesburg, FL
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site 15
2512
mi
from 98109
Leesburg, FL
Click here to add this to my saved trials
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site
2171
mi
from 98109
Atlanta, GA
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site
2171
mi
from 98109
Atlanta, GA
Click here to add this to my saved trials
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site
1732
mi
from 98109
Chicago, IL
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site
1732
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site
2324
mi
from 98109
Baltimore, MD
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site
2324
mi
from 98109
Baltimore, MD
Click here to add this to my saved trials
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site 006
2309
mi
from 98109
Rockville, MD
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site 006
2309
mi
from 98109
Rockville, MD
Click here to add this to my saved trials
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site 001
1974
mi
from 98109
Flowood, MS
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site 001
1974
mi
from 98109
Flowood, MS
Click here to add this to my saved trials
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site 022
1708
mi
from 98109
Creve Coeur, MO
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site 022
1708
mi
from 98109
Creve Coeur, MO
Click here to add this to my saved trials
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Forest Investigative site 026
1956
mi
from 98109
Dayton, OH
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Forest Investigative site 026
1956
mi
from 98109
Dayton, OH
Click here to add this to my saved trials
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site 014
1770
mi
from 98109
Austin, TX
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site 014
1770
mi
from 98109
Austin, TX
Click here to add this to my saved trials
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site 014
1770
mi
from 98109
Austin, TX
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site 014
1770
mi
from 98109
Austin, TX
Click here to add this to my saved trials
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site
1675
mi
from 98109
Dallas, TX
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site
1675
mi
from 98109
Dallas, TX
Click here to add this to my saved trials
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site
1887
mi
from 98109
Houston, TX
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site
1887
mi
from 98109
Houston, TX
Click here to add this to my saved trials
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site
1887
mi
from 98109
Houston, TX
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site
1887
mi
from 98109
Houston, TX
Click here to add this to my saved trials
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site 009
984
mi
from 98109
Orange, CA
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site 009
984
mi
from 98109
Orange, CA
Click here to add this to my saved trials
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site 008
2417
mi
from 98109
Cedarhurst, NY
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site 008
2417
mi
from 98109
Cedarhurst, NY
Click here to add this to my saved trials
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site 1559
1720
mi
from 98109
Saint Louis, MO
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site 1559
1720
mi
from 98109
Saint Louis, MO
Click here to add this to my saved trials
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Forest Investigative Site 305
mi
from 98109
Vijayawada,
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Cariprazine (RGH-188) in the Prevention of Relapse in Patients With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Forest Investigative Site 305
mi
from 98109
Vijayawada,
Click here to add this to my saved trials
Electronic Decision Support Systems for Smokers With Severe Mental Illness
Electronic Decision Support Systems for Smokers With Severe Mental Illness
Status: Enrolling
Updated:  12/31/1969
Thresholds Psychiatric Rehabilitation Center
1733
mi
from 98109
Chicago, IL
Electronic Decision Support Systems for Smokers With Severe Mental Illness
Electronic Decision Support Systems for Smokers With Severe Mental Illness
Status: Enrolling
Updated: 12/31/1969
Thresholds Psychiatric Rehabilitation Center
1733
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
1782
mi
from 98109
Little Rock, AR
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
1782
mi
from 98109
Little Rock, AR
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
976
mi
from 98109
Cerritos, CA
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
976
mi
from 98109
Cerritos, CA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
2322
mi
from 98109
Washington,
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
2322
mi
from 98109
Washington,
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
2178
mi
from 98109
Atlanta, GA
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
2178
mi
from 98109
Atlanta, GA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
1733
mi
from 98109
Chicago, IL
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
1733
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
1704
mi
from 98109
Hoffman Estates, IL
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
1704
mi
from 98109
Hoffman Estates, IL
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
1503
mi
from 98109
Overland Park, KA
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
1503
mi
from 98109
Overland Park, KA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
2310
mi
from 98109
Rockville, MD
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
2310
mi
from 98109
Rockville, MD
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
2373
mi
from 98109
Philadelphia, PA
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
2373
mi
from 98109
Philadelphia, PA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
2423
mi
from 98109
Charleston, SC
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
2423
mi
from 98109
Charleston, SC
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
1770
mi
from 98109
Austin, TX
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
1770
mi
from 98109
Austin, TX
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
1639
mi
from 98109
Springdale, AR
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
1639
mi
from 98109
Springdale, AR
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
982
mi
from 98109
Garden Grove, CA
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
982
mi
from 98109
Garden Grove, CA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
973
mi
from 98109
La Habra, CA
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
973
mi
from 98109
La Habra, CA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
678
mi
from 98109
Oakland, CA
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
678
mi
from 98109
Oakland, CA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
1031
mi
from 98109
Oceanside, CA
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
1031
mi
from 98109
Oceanside, CA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
984
mi
from 98109
Orange, CA
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
984
mi
from 98109
Orange, CA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
1059
mi
from 98109
San Diego, CA
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
1059
mi
from 98109
San Diego, CA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
2512
mi
from 98109
Leesburg, FL
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
2512
mi
from 98109
Leesburg, FL
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
1709
mi
from 98109
Creve Coeur, MO
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
1709
mi
from 98109
Creve Coeur, MO
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
1677
mi
from 98109
Dallas, TX
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
1677
mi
from 98109
Dallas, TX
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
5941
mi
from 98109
Burgas,
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
5941
mi
from 98109
Burgas,
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
2715
mi
from 98109
Fort Lauderdale, FL
A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of ALKS 9072 in Subjects With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
2715
mi
from 98109
Fort Lauderdale, FL
Click here to add this to my saved trials